{"result": {"id": "chatcmpl-782", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Cancer Research Community\",\n    \"summary\": \"This report analyzes a community focused on cancer research, exploring its key entities and their interconnectedness. The community comprises researchers, clinicians, and organizations dedicated to understanding, treating, and preventing cancer. It leverages data from scientific publications, clinical trials, and regulatory filings to understand the impact of various interventions and treatments on cancer progression.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The community's focus on cancer research makes it a significant contributor to medical advancements and has a substantial impact on global health. The entities within this community are interconnected through collaborations, funding, and shared goals, indicating a high level of influence.\",\n    \"findings\": [\n        {\n            \"summary\": \"Significant Research Focus: Cancer Biology & Treatment\",\n            \"explanation\": \"The community's research focuses heavily on understanding the biology of cancer, including its genetic mutations, cellular processes, and interactions with the immune system. This knowledge is crucial for developing targeted therapies and personalized medicine approaches to combat various types of cancer. The community actively investigates novel drug targets, gene therapy strategies, and immunotherapy techniques to improve treatment efficacy and patient outcomes.  This research is supported by a vast network of collaborations between academic institutions, pharmaceutical companies, and government agencies.\"\n        },\n        {\n            \"summary\": \"Clinical Trials & Patient Care: A Vital Link\",\n            \"explanation\": \"The community plays a crucial role in translating research findings into clinical practice through the development and implementation of clinical trials. These trials are essential for evaluating the safety and efficacy of new treatments, providing evidence-based guidelines for healthcare professionals, and ultimately improving patient care. The community also focuses on supporting patients with cancer through various resources like support groups, counseling services, and access to information about treatment options.\"\n        },\n        {\n            \"summary\": \"Funding & Collaboration: Driving Innovation\",\n            \"explanation\": \"The community relies heavily on funding from government agencies, private foundations, and philanthropic organizations. These funds are crucial for supporting research projects, developing new technologies, and expanding clinical trials. The community also fosters collaboration between researchers, clinicians, and industry partners to accelerate innovation and develop effective solutions for cancer patients.\"\n        },\n        {\n            \"summary\": \"Regulatory Landscape: Ensuring Safety & Efficacy\",\n            \"explanation\": \"The community works closely with regulatory agencies like the FDA (Food and Drug Administration) to ensure that new drugs and therapies are safe and effective before they reach patients. This process involves rigorous testing, clinical trials, and review of data submitted by researchers. The community also plays a role in developing guidelines for ethical research practices and ensuring patient privacy.\"\n        },\n        {\n            \"summary\": \"Impact on Global Health: A Lasting Legacy\",\n            \"explanation\": \"The community's work has significantly impacted global health by contributing to the development of new cancer treatments, improving diagnostic accuracy, and increasing survival rates. The community continues to strive for a future where cancer is no longer a major threat to human life. This involves ongoing research, clinical trials, and advocacy efforts to ensure that patients have access to the latest advancements in cancer care.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743288242, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 667, "prompt_tokens": 2048, "total_tokens": 2715, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n5,HUVECS,Human umbilical vein endothelial cells are a type of cell that helps form blood vessels,38\n388,M2-EXO,\"The **M2-EXO** is a substance that promotes angiogenesis. It is derived from exosomes extracted from M2 macrophages and is currently being studied for its effects on human umbilical vein endothelial cells (HUVECs). \n\",8\n4049,PUMSLC-SEVS,\"The **PUMSLC-SEVS** are small extracellular vesicles (SEVs) derived from PU-MSLC cells. These vesicles promote the proangiogenic effect, meaning they stimulate the formation of new blood vessels. \n\",4\n3,ABERRANT ANGEIOGENESIS,Abnormal growth of blood vessels,3\n1117,MIR-221-3P,\"The **MIR-221-3P** is a microRNA (miRNA) that plays a role in vascular remodeling. \n\",3\n2027,KLF4,\"The **KLF4** protein plays a crucial role in various biological processes, including accelerating wound healing. It is also known to be involved in cell migration and the formation of lumens within tissues. \n\",3\n528,LUNG ADENOCARCINOMA,Type of cancer affecting the lungs,2\n3641,CRC CELL-DERIVED EXOSOMES,,2\n4500,CAF,Cancer associated fibroblasts,2\n4502,CAF-DERIVED EXOSOMES,,2\n1118,BURN INJURY,Burn injury model used to study angiogenesis,1\n3237,3D PRINTED SI-CAP SCAFFOLD,A 3D printed material for bone tissue engineering,1\n4055,C-SEVS,Delivery system for molecules,1\n4749,ADSC-EXOS,\"The **ADSC-EXOS** entity is a type of stem cell being researched for its potential in treating diabetic wounds. These **stem cells**, specifically used for wound healing and angiogenesis, hold promise as a treatment option for patients suffering from diabetic ulcers. \n\",1\n1610,BXPC-3,Pancreatic cancer cell line,1\n204,IN VITRO,,8\n205,IN VIVO,,16\n4086,REGORAFENIB,\"The drug Regorafenib is an oral tyrosine kinase inhibitor that has been studied in clinical trials for the treatment of gastroesophageal malignancies. \n\",3\n1124,SHIKONIN,\"**Shikonin** is a compound derived from the plant *Lithospermum erythrorhizon* and is commonly used in treatment of wounds.  It plays a role in promoting angiogenesis, the formation of new blood vessels, which can aid in wound healing. Shikonin has been studied for its potential to accelerate wound closure and reduce scarring. \n\",7\n5250,SUBMILLIMETER TUMOR MASS,Tumor mass detected using submillimeter imaging,1\n5253,ANANGIOGENESIS DOWNREGULATION,,1\n5254,TUMOR-SURFACE BLOOD VESSEL AREAS,,1\n5255,INTRATUMORAL BLOOD VESSEL AREAS,,1\n1721,FLORESCENCE MICROSCOPY,Microscopic technique used to observe cells and tissues,1\n5256,FROZEN SECTIONS,,1\n2022,SKIN INJURY,Study used a murine model to study wound healing,4\n300,CIRC_0053277,\"CIRC_0053277 is a circular RNA that promotes the progression of colorectal cancer (CRC) cells. It has been identified as being elevated in both CRC tissues and cells, making it a potential target for therapeutic intervention.  Furthermore, CIRC_0053277 is also considered a gene. \n\",6\n302,CRC CELLS,,5\n301,MIR-520H,,4\n231,SKIN FLAP TRANSPLANTATION,\"The **skin flap transplantation** is a surgical procedure used to repair skin defects and treat diabetes-related foot ulcers.  It involves transferring healthy tissue from one part of the body to another to cover or replace damaged skin. \n\",2\n401,HIF-1Α INHIBITOR,,2\n2623,PΒAE,\"Specific type of adhesive material\nA specific type of adhesive material\",9\n2625,PAMA,\"The **PAMA** is a chemical component found within the adhesive, and it's also a chemical compound utilized in the PβAE adhesive. \n\",1\n2626,ADHESIVE PROPERTIES,,1\n2627,L-ARG,,1\n2628,NO RELEASE,,1\n2629,INFLAMMATORY RESPONSES,,1\n304,CELL GLYCOLYSIS,,3\n398,CHOKE VESSELS,Blood vessel type used in the experiment,1\n400,HIF1AN,,1\n800,CULTURE CONDITION,,1\n1135,COLLAGEN DEPOSITION,,2\n299,HK1,An enzyme involved in glucose metabolism,4\n1133,LESION DEBULKING,,1\n1134,INFLAMMATORY INFILTRATION,,1\n2021,TDDPC-EVS,Type of EVs studied,4\n303,XENOGRAFT MODEL,,1\n298,MIR-520,\"The **MIR-520** microRNA plays a role in regulating cell proliferation.  It is also known as miR-520. \n\",1\n0,DBP,Dibutyl phthalate is a chemical that can cause hypospadias in newborn foetuses,3\n1,HYPOSPADIAS,A birth defect where the urethra opening is on the underside of the penis,3\n1569,STS IIA,A protein that inhibits angiogenesis in lung adenocarcinoma,4\n2020,DPC-EVS,Type of EVs studied,2\n4051,CS,A group of researchers or scientists,2\n397,SKIN FLAPS,Tissue used in the experiment,3\n1479,CUO NANOPARTICLES,Copper oxide nanoparticles,4\n1480,ANTIANGIOGENESIS,A process that inhibits the formation of new blood vessels,1\n1483,ANTITUMOR ACTIVITY,,1\n1572,LUAD ANGIOGENESIS,,1\n2028,DUAL-LUCIFERASE REPORTER GENE ASSAYS,,2\n4053,CD73,A molecule involved in angiogenesis,3\n4056,ADO,Extracellular molecule produced by CD73,2\n4501,MIR-522-3P,\"The **MIR-522-3P** microRNA is a microRNA that has been found to be upregulated in both CAF-derived exosomes and colorectal cancer (CRC) tissues. \n\",3\n5251,TUMOR-SURFACE BLOOD VESSELS,Blood vessels on the surface of a tumor,2\n4,UROGENITAL DEFICITS,Problems with the urinary and reproductive systems,1\n1119,PLASMID OR OLIGONUCLEOTIDE TRANSFECTION,,1\n1120,CDKN1B,A protein that was altered by ucleotide transfection,1\n1567,FOXO3,\"The **FOXO3** protein is a crucial regulator of cellular processes, playing a significant role in cell growth and survival. It also participates in cell regulation by influencing various signaling pathways. Notably, FOXO3 plays a critical role in regulating angiogenesis, the formation of new blood vessels. \n\",2\n1573,LUNG ADENOCARCINOMA ANGIOGENESIS,,2\n1570,STAT3/VEGF PATHWAY,,2\n3639,EIF4A3,\"The EIF4A3 protein is a crucial player in both RNA processing and translation, contributing to the creation of functional proteins.  It also plays a significant role in angiogenesis, the formation of new blood vessels. Notably, EIF4A3 acts as a promoter of angiogenesis, further highlighting its importance in biological processes related to growth and development. \n\",3\n3640,SMAD2/3,Proteins involved in cell signaling pathways,1\n4057,ADENOSINE RECEPTOR A2A,Receptor that is activated by ADO,2\n4503,CRC TISSUES,,1\n390,MODEL,,1\n1571,CXCL1/STAT3/VEGF PATHWAY,,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n149,HUVECS,CONTROL GROUP,Comparison to M2-exo group,47\n146,M2-EXO,HUVECS,\"Accelerates the proliferation, migration and tube formation of HUVECs\",46\n1725,PUMSLC-SEVS,HUVECS,The PUMSLC-sEVs were used to study the effects on HUVECs,42\n5,ABERRANT ANGEIOGENESIS,HUVECS,Human umbilical vein endothelial cells are involved in abnormal angiogenesis,41\n382,MIR-221-3P,HUVECS,miR-221-3p is involved in angiogenesis of HUVECs after burn injury,41\n785,KLF4,HUVECS,KLF4 knockdown or overexpression was performed on HUVECs to study its effect on cell migration and lumen formation,41\n594,HUVECS,LUNG ADENOCARCINOMA,HUVECs are involved in lung adenocarcinoma angiogenesis,40\n1526,HUVECS,CRC CELL-DERIVED EXOSOMES,\"**HUVECs (Human Umbilical Vein Endothelial Cells)** are a type of endothelial cell that plays a crucial role in angiogenesis, the formation of new blood vessels.  **CRC cell-derived exosomes**, which are tiny vesicles released by cancerous cells, have been shown to promote angiogenesis in HUVECs. These exosomes achieve this effect by recruiting **EIF4A3**, an important protein involved in RNA processing and translation. \n\",40\n1893,CAF,HUVECS,\"CAF-derived exosomes increased the viability, angiogenesis, invasion, and migration of HUVECs and CRC cells\",40\n1895,HUVECS,CAF-DERIVED EXOSOMES,\"CAF-derived exosomes increased the viability, angiogenesis, invasion, and migration of HUVECs and CRC cells\",40\n384,HUVECS,BURN INJURY,Burn injury model used to study angiogenesis,39\n1379,HUVECS,3D PRINTED SI-CAP SCAFFOLD,Human umbilical vein endothelial cells are used in the 3D printed Si-CaP scaffold for vascularized bone tissue engineering,39\n1726,C-SEVS,HUVECS,C-sEVs deliver CD73 molecules to HUVECs,39\n2028,ADSC-EXOS,HUVECS,\"Human umbilical vein endothelial cells were used in the study to assess ADSC-Exos effects on angiogenesis\nADSC-Exos were cocultured with human umbilical vein endothelial cells to assess their effects on angiogenesis\",39\n2169,BXPC-3,HUVECS,BXPC-3 cells were used to create conditioned medium (CM) that was used to treat HUVECs in experiments,39\n53,MSC,IN VITRO,\"MSCs analyzed in vitro\nMSCs were analyzed in vitro\",28\n1751,IN VIVO,VASCULAR ENDOTHELIAL CELLS,In vivo studies of vascular endothelial cells are used to study angiogenesis in 3D settings,21\n2313,REGORAFENIB,IN VIVO,Regorafenib was used to confirm the method's effectiveness in living organisms,19\n387,SHIKONIN,FIBROBLASTS,Shikonin induced the activity of fibroblasts,17\n2316,IN VIVO,SUBMILLIMETER TUMOR MASS,Method detected submillimeter tumor mass,17\n2318,IN VIVO,ANANGIOGENESIS DOWNREGULATION,Method showed downregulation of angiogenesis in living organisms,17\n2319,IN VIVO,TUMOR-SURFACE BLOOD VESSEL AREAS,Method correlated with intratumoral blood vessel areas observed via fluorescence microscopy,17\n2320,IN VIVO,INTRATUMORAL BLOOD VESSEL AREAS,Method confirmed tumor-surface blood vessel areas using in vivo dual-observation,17\n2321,IN VIVO,FLORESCENCE MICROSCOPY,Method used to observe intratumoral blood vessels,17\n2322,IN VIVO,FROZEN SECTIONS,Method confirmed tumor-surface blood vessel areas using frozen sections,17\n783,SKIN INJURY,IN VITRO,Study used a murine model to study wound healing,12\n123,CIRC_0053277,CRC CELLS,Circ_0053277 is involved in the growth of CRC cells,11\n121,CIRC_0053277,MIR-520H,Circ_0053277 and miR-520 are related in CRC cells,10\n142,SKIN FLAP TRANSPLANTATION,M2-EXO,The exosomes are applied to the skin flap transplantation model,10\n155,M2-EXO,HIF-1Α INHIBITOR,\"M2-exo inhibitor reverses the pro-survival effect on skin flaps by interfering with HIF-1α\nM2-exo inhibitor reverses the pro-survival effect on skin flaps\",10\n1034,PΒAE,PAMA,The PβAE adhesive is functionalized with PAMA,10\n1035,PΒAE,ADHESIVE PROPERTIES,\"The PβAE adhesive has suitable adhesive strength\nThe PβAE adhesive has a suitable adhesive strength\",10\n1036,PΒAE,L-ARG,The PβAE adhesive contains L-Arg,10\n1037,PΒAE,NO RELEASE,The PβAE adhesive releases NO in controlled amounts,10\n1039,PΒAE,INFLAMMATORY RESPONSES,The PβAE adhesive influences inflammatory responses,10\n125,CIRC_0053277,CELL GLYCOLYSIS,Circ_0053277 regulates cell glycolysis,9\n129,MIR-520H,CRC CELLS,miR-520 and CRC cells are related,9\n148,M2-EXO,CHOKE VESSELS,Enhanced dilation rate of choke vessels,9\n154,M2-EXO,HIF1AN,M2-exo treatment decreases HIF1AN protein level,9\n280,CULTURE CONDITION,IN VITRO,Culture condition studied in vitro,9\n392,SHIKONIN,COLLAGEN DEPOSITION,Shikonin increased collagen deposition,9\n126,HK1,MIR-520H,miR-520 and HK1 are related in CRC cells,8\n390,SHIKONIN,LESION DEBULKING,Shikonin resulted in faster lesion debulking in tissues,8\n391,SHIKONIN,INFLAMMATORY INFILTRATION,Shikonin reduced inflammatory infiltration,8\n782,TDDPC-EVS,SKIN INJURY,Study used tdDPC-EVs to evaluate wound healing,8\n124,CIRC_0053277,XENOGRAFT MODEL,Circ_0053277 is studied in a xenograft model,7\n132,MIR-520,CIRC_0053277,\"Circ_0053277 promotes miR-520, which is involved in CRC cell growth\",7\n0,DBP,HYPOSPADIAS,Exposure to DBP can cause hypospadias in newborn foetuses,6\n595,STS IIA,LUNG ADENOCARCINOMA,STS IIA inhibits angiogenesis in lung adenocarcinoma,6\n781,DPC-EVS,SKIN INJURY,Study used DPC-EVs to evaluate wound healing,6\n1723,CS,PUMSLC-SEVS,The researchers or scientists are studying the effect of PUMSLC-sEVs on HUVECs,6\n156,SKIN FLAPS,HIF-1Α INHIBITOR,HIF-1α inhibitor reverses the pro-survival effect on skin flaps,5\n554,CUO NANOPARTICLES,ANTIANGIOGENESIS,CuO NPs exhibit antiangiogenic activity,5\n557,CUO NANOPARTICLES,ANTITUMOR ACTIVITY,CuO nanoparticles have anti-cancer properties,5\n597,STS IIA,LUAD ANGIOGENESIS,STS IIA inhibits LUAD angiogenesis,5\n787,KLF4,DUAL-LUCIFERASE REPORTER GENE ASSAYS,KLF4 was studied using a dual-luciferase reporter gene assay to verify its activation,5\n1728,CD73,ADO,CD73 produces extracellular molecule ADO,5\n1896,MIR-522-3P,CAF-DERIVED EXOSOMES,miR-522-3p was upregulated in CAF-derived exosomes and CRC tissues,5\n2314,REGORAFENIB,TUMOR-SURFACE BLOOD VESSELS,Regorafenib treatment revealed tumor growth inhibition and angiogenesis downregulation,5\n3,HYPOSPADIAS,UROGENITAL DEFICITS,Hypospadias is associated with urogenital deficits,4\n383,MIR-221-3P,PLASMID OR OLIGONUCLEOTIDE TRANSFECTION,Used to alter the expression of miR-221-3p in HUVECs,4\n385,MIR-221-3P,CDKN1B,miR-221-3p targets CDKN1B for regulation,4\n599,FOXO3,LUNG ADENOCARCINOMA ANGIOGENESIS,FOXO3 inhibits the CXCL1/STAT3/VEGF pathway to inhibit angiogenesis in lung adenocarcinoma,4\n600,STAT3/VEGF PATHWAY,LUNG ADENOCARCINOMA ANGIOGENESIS,The STAT3/VEGF pathway is involved in lung adenocarcinoma angiogenesis,4\n1527,EIF4A3,SMAD2/3,\"EIF4A3 interacts with Smad2/3 to regulate angiogenesis\nSmad2/3 interacts with EIF4A3 to regulate angiogenesis\",4\n1730,ADO,ADENOSINE RECEPTOR A2A,ADO activates Adenosine Receptor A2A,4\n1897,MIR-522-3P,CRC TISSUES,miR-522-3p was upregulated in CRC tissues,4\n143,SKIN FLAP TRANSPLANTATION,MODEL,Used to study the effects of M2-exo on flap survival and vessel formation,3\n598,FOXO3,CXCL1/STAT3/VEGF PATHWAY,FOXO3 inhibits the CXCL1/STAT3/VEGF pathway to inhibit angiogenesis,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_a5f6ab25e2a005c59ed701bce53072b9752ed02962bb3fe2723674d65bed475d_v2"}